OLIGOMER BONDED TO NUCLEIC ACID

PROBLEM TO BE SOLVED: To obtain the subject new compound having new C-branches and N-branches, suitable for suppressing the expression of genes, exhibiting an antiviral property and useful for treating virus-infected diseases or cancers. SOLUTION: A compound of formula I [A is CO, etc.; B is thymine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SCHWEMLER CHRISTOPH DR, STROPP UDO DR, KOSCH WINFRIED DR, JORDAN STEPHAN DR, KRETSCHMER AXEL DR
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SCHWEMLER CHRISTOPH DR
STROPP UDO DR
KOSCH WINFRIED DR
JORDAN STEPHAN DR
KRETSCHMER AXEL DR
description PROBLEM TO BE SOLVED: To obtain the subject new compound having new C-branches and N-branches, suitable for suppressing the expression of genes, exhibiting an antiviral property and useful for treating virus-infected diseases or cancers. SOLUTION: A compound of formula I [A is CO, etc.; B is thymine, acetyl, etc.; C is CH, etc.; D is NH, etc.; E is NRR' (R, R' are each OH, methyl, etc., F is CH2 , etc.; G is NH, etc.; H is CR R (R is H, methyl; R is H, a 1-4C alkyl, etc.), etc.; L is (CH2 )p ((p) is 0-2), etc.; M is CH2 , etc.; Q is OH, O, etc.; T is hydroxyl group, etc.; (r) is 0, 1; (s) is 1-30], e.g. δ-N-Boc-α-N-L-ornithine methyl ester. The compound of formula I is produced e.g. by subjecting δ-N-Boc- protected L-ornithine methyl ester to a reductive amination reaction to introduce a benzyl protecting group, subjecting the obtained compound of formula II to an α-N-methylation reaction, introducing a nucleic acid base to the obtained compound of formula II, and subsequently hydrolyzing the compound of formula IV. The produced compound of formula I is suitable for oligomerization.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH1087634A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH1087634A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH1087634A3</originalsourceid><addsrcrecordid>eNrjZJD39_F09_d1DVJw8vdzcXVRCPFX8At19nH1dFZwdPZ04WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8V4BHoYGFuZmxiaOxkQoAQB7nCEh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OLIGOMER BONDED TO NUCLEIC ACID</title><source>esp@cenet</source><creator>SCHWEMLER CHRISTOPH DR ; STROPP UDO DR ; KOSCH WINFRIED DR ; JORDAN STEPHAN DR ; KRETSCHMER AXEL DR</creator><creatorcontrib>SCHWEMLER CHRISTOPH DR ; STROPP UDO DR ; KOSCH WINFRIED DR ; JORDAN STEPHAN DR ; KRETSCHMER AXEL DR</creatorcontrib><description>PROBLEM TO BE SOLVED: To obtain the subject new compound having new C-branches and N-branches, suitable for suppressing the expression of genes, exhibiting an antiviral property and useful for treating virus-infected diseases or cancers. SOLUTION: A compound of formula I [A is CO, etc.; B is thymine, acetyl, etc.; C is CH, etc.; D is NH, etc.; E is NRR' (R, R' are each OH, methyl, etc., F is CH2 , etc.; G is NH, etc.; H is CR R (R is H, methyl; R is H, a 1-4C alkyl, etc.), etc.; L is (CH2 )p ((p) is 0-2), etc.; M is CH2 , etc.; Q is OH, O, etc.; T is hydroxyl group, etc.; (r) is 0, 1; (s) is 1-30], e.g. δ-N-Boc-α-N-L-ornithine methyl ester. The compound of formula I is produced e.g. by subjecting δ-N-Boc- protected L-ornithine methyl ester to a reductive amination reaction to introduce a benzyl protecting group, subjecting the obtained compound of formula II to an α-N-methylation reaction, introducing a nucleic acid base to the obtained compound of formula II, and subsequently hydrolyzing the compound of formula IV. The produced compound of formula I is suitable for oligomerization.</description><edition>6</edition><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1998</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19980407&amp;DB=EPODOC&amp;CC=JP&amp;NR=H1087634A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19980407&amp;DB=EPODOC&amp;CC=JP&amp;NR=H1087634A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHWEMLER CHRISTOPH DR</creatorcontrib><creatorcontrib>STROPP UDO DR</creatorcontrib><creatorcontrib>KOSCH WINFRIED DR</creatorcontrib><creatorcontrib>JORDAN STEPHAN DR</creatorcontrib><creatorcontrib>KRETSCHMER AXEL DR</creatorcontrib><title>OLIGOMER BONDED TO NUCLEIC ACID</title><description>PROBLEM TO BE SOLVED: To obtain the subject new compound having new C-branches and N-branches, suitable for suppressing the expression of genes, exhibiting an antiviral property and useful for treating virus-infected diseases or cancers. SOLUTION: A compound of formula I [A is CO, etc.; B is thymine, acetyl, etc.; C is CH, etc.; D is NH, etc.; E is NRR' (R, R' are each OH, methyl, etc., F is CH2 , etc.; G is NH, etc.; H is CR R (R is H, methyl; R is H, a 1-4C alkyl, etc.), etc.; L is (CH2 )p ((p) is 0-2), etc.; M is CH2 , etc.; Q is OH, O, etc.; T is hydroxyl group, etc.; (r) is 0, 1; (s) is 1-30], e.g. δ-N-Boc-α-N-L-ornithine methyl ester. The compound of formula I is produced e.g. by subjecting δ-N-Boc- protected L-ornithine methyl ester to a reductive amination reaction to introduce a benzyl protecting group, subjecting the obtained compound of formula II to an α-N-methylation reaction, introducing a nucleic acid base to the obtained compound of formula II, and subsequently hydrolyzing the compound of formula IV. The produced compound of formula I is suitable for oligomerization.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1998</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD39_F09_d1DVJw8vdzcXVRCPFX8At19nH1dFZwdPZ04WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8V4BHoYGFuZmxiaOxkQoAQB7nCEh</recordid><startdate>19980407</startdate><enddate>19980407</enddate><creator>SCHWEMLER CHRISTOPH DR</creator><creator>STROPP UDO DR</creator><creator>KOSCH WINFRIED DR</creator><creator>JORDAN STEPHAN DR</creator><creator>KRETSCHMER AXEL DR</creator><scope>EVB</scope></search><sort><creationdate>19980407</creationdate><title>OLIGOMER BONDED TO NUCLEIC ACID</title><author>SCHWEMLER CHRISTOPH DR ; STROPP UDO DR ; KOSCH WINFRIED DR ; JORDAN STEPHAN DR ; KRETSCHMER AXEL DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH1087634A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1998</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHWEMLER CHRISTOPH DR</creatorcontrib><creatorcontrib>STROPP UDO DR</creatorcontrib><creatorcontrib>KOSCH WINFRIED DR</creatorcontrib><creatorcontrib>JORDAN STEPHAN DR</creatorcontrib><creatorcontrib>KRETSCHMER AXEL DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHWEMLER CHRISTOPH DR</au><au>STROPP UDO DR</au><au>KOSCH WINFRIED DR</au><au>JORDAN STEPHAN DR</au><au>KRETSCHMER AXEL DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OLIGOMER BONDED TO NUCLEIC ACID</title><date>1998-04-07</date><risdate>1998</risdate><abstract>PROBLEM TO BE SOLVED: To obtain the subject new compound having new C-branches and N-branches, suitable for suppressing the expression of genes, exhibiting an antiviral property and useful for treating virus-infected diseases or cancers. SOLUTION: A compound of formula I [A is CO, etc.; B is thymine, acetyl, etc.; C is CH, etc.; D is NH, etc.; E is NRR' (R, R' are each OH, methyl, etc., F is CH2 , etc.; G is NH, etc.; H is CR R (R is H, methyl; R is H, a 1-4C alkyl, etc.), etc.; L is (CH2 )p ((p) is 0-2), etc.; M is CH2 , etc.; Q is OH, O, etc.; T is hydroxyl group, etc.; (r) is 0, 1; (s) is 1-30], e.g. δ-N-Boc-α-N-L-ornithine methyl ester. The compound of formula I is produced e.g. by subjecting δ-N-Boc- protected L-ornithine methyl ester to a reductive amination reaction to introduce a benzyl protecting group, subjecting the obtained compound of formula II to an α-N-methylation reaction, introducing a nucleic acid base to the obtained compound of formula II, and subsequently hydrolyzing the compound of formula IV. The produced compound of formula I is suitable for oligomerization.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JPH1087634A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title OLIGOMER BONDED TO NUCLEIC ACID
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A29%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHWEMLER%20CHRISTOPH%20DR&rft.date=1998-04-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH1087634A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true